Sionna Therapeutics, Inc.

NASDAQ:SION

Biotechnology

Healthcare
$2.97 +1.85%

+$0.68 today

Market cap
$134.35M
Beta
1.29
P/E (TTM)
-19.7
EPS (TTM)
-$1.90
52W Low $13.81High $48.45

Volume 0.65M

Average 0.39M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$66.30M

FY 2025 · Annual

Investing Cash Flow

-$118.75M

FY 2025 · Annual

Financing Cash Flow

$205.71M

FY 2025 · Annual

+14.9% YoY

Cash Flow Statement

USD
Metric
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(40.24M)(47.26M)(61.69M)(75.27M)
Depreciation & Amortization122K583K668K(3.05M)
Deferred Income Tax0000
Stock-Based Compensation1.69M2.26M3.71M12.07M
Change in Working Capital2.76M(783K)(3.08M)(2.65M)
Accounts Receivables0000
Inventory0000
Accounts Payables(1.51M)162K467K(417K)
Other Working Capital4.28M(945K)(3.54M)(2.24M)
Other Non-Cash Items(400K)1.51M7.6M2.61M
Operating Cash Flow(36.07M)(43.7M)(52.79M)(66.3M)
Capital Expenditures(1.87M)(1.12M)(27K)(377K)
Acquisitions (Net)0000
Purchases of Investments(40.39M)(23.53M)(182.84M)(325.03M)
Sales of Investments13M52M55.96M206.65M
Other Investing Activities0000
Investing Cash Flow(29.26M)27.35M(126.91M)(118.75M)
Debt Repayment0000
Common Stock Issued00178.97M205.71M
Common Stock Repurchased0000
Dividends Paid0000
Other Financing Activities64K31K00
Financing Cash Flow110.86M31K178.97M205.71M
Effect of Forex Changes0000
Net Change in Cash45.52M(16.32M)(733K)20.66M
Free Cash Flow(37.94M)(44.82M)(52.81M)(66.67M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$75.3M
+ D&A-$3.1M
+ Stock-Based Comp$12.1M
+ Deferred Tax$0
- Working Capital-$2.7M
+ Other Non-Cash$2.6M
= Operating Cash Flow-$66.3M
- Capex-$377.0K
= Free Cash Flow-$66.7M

Analysis

FY2025 free cash flow is -$66.7M. FCF conversion is 88.6% of net income. Operating cash flow was -$66.3M, with capex of -$377.0K. The largest bridge item is Stock-Based Comp at $12.1M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 10, 2026
8-KCurrent reportNov 10, 2026
SC 13GSC 13G filingNov 9, 2026
SC 13D/ASC 13D/A filingSep 21, 2026
4Statement of changes in beneficial ownershipSep 21, 2026

Does SION generate free cash flow?

Sionna Therapeutics, Inc. (SION) generated -$66.67M of free cash flow in fiscal 2025.

How much operating cash flow does SION produce?

Operating cash flow was -$66.30M, before capital expenditures of $377,000.00.